• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosgenPLoS GeneticsSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
PLoS Genet. Oct 2006; 2(10): e172.
Published online Oct 20, 2006. Prepublished online Aug 28, 2006. doi:  10.1371/journal.pgen.0020172
PMCID: PMC1617131

Heritability and Tissue Specificity of Expression Quantitative Trait Loci

Jonathan Flint, Editor

Abstract

Variation in gene expression is heritable and has been mapped to the genome in humans and model organisms as expression quantitative trait loci (eQTLs). We applied integrated genome-wide expression profiling and linkage analysis to the regulation of gene expression in fat, kidney, adrenal, and heart tissues using the BXH/HXB panel of rat recombinant inbred strains. Here, we report the influence of heritability and allelic effect of the quantitative trait locus on detection of cis- and trans-acting eQTLs and discuss how these factors operate in a tissue-specific context. We identified several hundred major eQTLs in each tissue and found that cis-acting eQTLs are highly heritable and easier to detect than trans-eQTLs. The proportion of heritable expression traits was similar in all tissues; however, heritability alone was not a reliable predictor of whether an eQTL will be detected. We empirically show how the use of heritability as a filter reduces the ability to discover trans-eQTLs, particularly for eQTLs with small effects. Only 3% of cis- and trans-eQTLs exhibited large allelic effects, explaining more than 40% of the phenotypic variance, suggestive of a highly polygenic control of gene expression. Power calculations indicated that, across tissues, minor differences in genetic effects are expected to have a significant impact on detection of trans-eQTLs. Trans-eQTLs generally show smaller effects than cis-eQTLs and have a higher false discovery rate, particularly in more heterogeneous tissues, suggesting that small biological variability, likely relating to tissue composition, may influence detection of trans-eQTLs in this system. We delineate the effects of genetic architecture on variation in gene expression and show the sensitivity of this experimental design to tissue sampling variability in large-scale eQTL studies.

Synopsis

The combined application of genome-wide expression profiling from microarray experiments with genetic linkage analysis enables the mapping of expression quantitative trait loci (eQTLs), which are primary control points for gene expression across the genome. This approach has been called “genetical genomics”, and recent technological and methodological advances have made its large-scale application feasible in humans and model organisms. Using this approach, the authors have carried out an extensive analysis of the genetic architecture underlying variation in gene expression using a panel of 30 rat recombinant inbred strains. The results are used to explore the relationship between heritability of gene expression, cis- and trans-acting genetic effects, tissue heterogeneity, and statistical cut-offs of significance, which are important factors for large-scale eQTL studies. By examining large eQTL data from four tissues, the authors provide a detailed picture of cis- and trans-eQTL features that may help understanding of the genetic regulation of transcription on a genomic scale. The results also show the sensitivity of this approach to discriminate between cis and trans regulation and the value of the rat system in studying large eQTL datasets from multiple tissues.

Introduction

Quantitative variation in gene expression levels acts as an intermediate phenotype situated between genomic DNA sequence variation and more complex cellular, organ, or whole body phenotypes. Numerous studies indicate that individual variation in gene expression (i.e., transcript abundance) is heritable in segregating populations [15]. Gene expression can therefore be mapped to the genome using standard linkage methods, allowing identification of expression quantitative trait loci (eQTLs), which represent genomic regions for the genetic control of gene expression [6]. This approach has been termed genetical genomics [7,8], and recent technological and methodological advances have made its large-scale application feasible at the level of the genome. One of the most powerful features of this approach is the ability to discriminate between cis- and trans-acting influences on gene expression and potentially to dissect complex regulatory networks [9,10]. A cis-acting eQTL maps to the physical location of the gene itself, whereas a trans-acting eQTL maps to a genomic region that is distant from the physical location of the gene being transcribed. By combining the genomic position of the gene encoding each transcript and the position of its eQTL, it is possible to discriminate between cis- and trans-regulatory control elements of gene expression for thousands of genes across the genome.

A number of genetical genomics studies show that sequence variation in cis-acting genes plays a considerable role in determining detectable variability in gene expression, and, accordingly, cis effects are usually mapped with high statistical significance [3,11]. Cis-acting genes are generally easier to detect by linkage, since they explain a large fraction of the variance of gene expression, and are of great interest as positional candidates for physiological quantitative trait loci (QTLs) [12]. Although trans-eQTLs may be associated with lesser statistical significance, they are often detected as clusters, reflecting coordinated regulation of many genes by a single “master regulator” [5]. Trans-acting eQTL genes usually explain <20% of the phenotypic variance and may be below a stringent threshold of detection for linkage, since they may reflect genetic regulation that is dispersed across many loci with small effects [13]. Thus, trans-regulated genes appear to be more complex (i.e., under polygenic control) than the cis-regulated genes and likely reflect the additive outcome of genetic, epigenetic, and environmental regulation [8].

The ability to detect small differences in transcript abundance, or small allelic genetic effects, is partially a function of the power of the study but also relates to the use of corrections for multiple testing of variable stringency that are employed in genome-wide analyses [14]. In most eQTL studies, genome-wide thresholds for significance typically correspond to fold changes (FCs) in gene expression greater than 1.5–2 [15], which may limit the overall sensitivity to detect cis-acting effects. When one considers multiple datasets from specific tissues, different magnitudes of genetic effects may affect the relative proportions of detectable cis- and trans-eQTLs. To date, no large-scale assessment of the relative power to detect cis- and trans-acting eQTLs in a segregating population and across tissues has been reported. Although thousands of eQTLs are often reported in genetical genomics studies [3,5,11,16,17], the overall distribution of the eQTL genetic effects, heritability, and their relationship with power of eQTL mapping has not been described to our knowledge in any detail.

A central question arising from genetical genomics studies focuses on the relative sensitivity to detect cis- and trans-acting genetic variation as a function of (i) the heritability of gene expression, (ii) the genetic effect of the eQTL, (iii) the threshold of detection, (iv) the extent of polygenic regulation of gene expression, and (v) how these factors operate in a tissue-specific context [15]. To address these factors, we carried out a large-scale survey of quantitative genetics of transcription by means of integrated linkage analysis and expression profiling to the regulation of gene expression. We carried out this approach in the BXH/HXB panel of rat recombinant inbred (RI) strains, and four tissues were analysed. RI strains were derived by crossing the spontaneously hypertensive rat (SHR) with the normotensive Brown Norway (BN) strain to generate the BXH/HXB panel of 30 RI lines [18], one of the most widely used model systems of human hypertension and metabolic syndrome [1821]. Along with other features of the RI strains, the ability to make measurements in multiple genetically identical animals from the same strain increases trait heritability, thus facilitating eQTL identification [22,23]. This makes the RI lines an ideal model system to investigate the heritable component of gene expression for cis- and trans-acting regulators in the context of natural variation in complex physiological processes. Given that in similar study designs [16,17,24] high trait heritability has been used as one of the criteria for statistical significance to map eQTLs, we investigate the effect of heritability filtering on detection of cis- and trans-acting eQTLs. Here, we show how the overall sensitivity of the genetical genomics approach is determined by factors such as patterns of heritability of gene expression and tissue-specific genetic effects. We discuss how these factors affect the relative power to detect cis- and trans-eQTLs and highlight the importance of quantifying heritable determinants of gene expression in the context of single tissues.

Results

Heritability of Gene Expression in RI Strains

Gene expression profiles and trait heritability (h2trait) across 30 RI strains were investigated in fat, kidney, adrenal, and left ventricle (LV) tissue for each transcript considered in this study (see Materials and Methods). The median (25%–75% quartiles) h2trait is 0.14 (0.11–0.18) for LV, 0.17 (0.13–0.22) for fat, 0.14 (0.10–0.20) for kidney, and 0.17 (0.12–0.24) for adrenal. We observed that the distribution of heritable gene expression is comparable across tissues (p > 0.05, chi-square test; Figure S1), suggesting a similar extent of the genetic component segregating in the RI strains. The estimates of h2trait were positively correlated with the average levels of expression (Spearman's rank correlations: 0.33 in LV, 0.47 in fat, 0.1 in kidney, and 0.4 in adrenal, p < 0.05 in all tissues). We calculated the number of genes exhibiting different h2trait and observed no significant difference in the proportions of heritable transcripts across four tissues (Figure S2).

Global Analysis of Heritability and Allelic Effect of eQTLs in Four Tissues

Table 1 summarises the mapping results in four tissues for the major eQTLs (i.e., the eQTL with the highest statistical significance for each probeset) detected in cis or trans for each transcript. The median for h2trait, QTL effects, and heritability of the eQTLs (h2QTL) are also reported for each threshold of significance. For all major eQTLs detected at p = 0.05, the median h2trait ranges from a minimum of 0.14 for the trans-eQTLs to a maximum of 0.37 for the cis-eQTLs. At higher levels of significance the h2trait increases for both cis- and trans-acting eQTLs, but it is consistently lower for the trans-eQTLs (Table 1).

Table 1
Cis- and Trans-eQTLs Detected in LV, Fat, Kidney, and Adrenal Datasets at Different Genome-Wide Thresholds of Significance

At genome-wide significance (p = 0.05) eQTL effects are relatively small, ranging from 0.06 (trans-eQTLs) to 0.18 (cis-eQTLs). Median allelic effects increase at lower p-values up to 0.37 for cis-acting eQTLs and 0.11 for trans-acting eQTLs. The distribution of allelic effects in the range 0–1.5 (i.e., absolute FC in the range 1–8) and relative h2QTL for all major eQTLs mapped with genome-wide significance is reported in Figure 1. The vast majority of the eQTLs explained less than 40% of the genetic variance, suggesting that undetected eQTLs account for the rest of the variance in such transcripts. Notably, the strongest eQTLs explained >30% of genetic variance for ~26% of the transcripts, whereas only ~3% of both of cis- and trans-acting eQTLs (detected at high significance levels, p < 10−4) exhibited considerably large QTL effects and h2QTL > 0.4.

Figure 1
Genetic Architecture of Genetic Variation in Gene Expression

Heritability of Gene Expression for Detection of Cis- and Trans-eQTLs

We investigated the h2trait as a predictor of the existence of all significant eQTLs in LV, fat, kidney, and adrenal tissue, using receiver operating characteristic (ROC) curves (Figure S3). For the eQTLs detected at p = 0.05, the maximum area under the ROC curve (AUC) is 0.73 (standard error [SE] 0.007), which is commonly associated with inaccurate prediction [25]. Heritability appears to be a better predictor (minimum AUC in all tissues = 0.88 [SE 0.011], average AUC across tissues = 0.91) only for the eQTLs detected at p = 10−3 (Table S1). The ability of the h2trait to predict the existence of an eQTL improves by increasing the cut-off of significance for linkage, and at p = 10−5 the AUC is greater than 0.95 in all tissues (Figure S3; Table S1). We then considered the ability of heritability to predict the existence of cis- or trans-eQTLs separately. In all tissues, ROC analysis showed that h2trait is a poor predictor of the trans-eQTLs detected at p = 10−2: AUC ranges from 0.47 to 0.53. At each threshold of significance, the null hypothesis that the AUC equals 0.5 cannot be rejected for the trans-eQTLs. As such, the h2trait is no better than chance in predicting a detectable trans-eQTL. For the cis-eQTLs, we observed higher accuracy in the prediction: AUC ranges from 0.69 (eQTLs detected at p = 10−2) to 0.77 (eQTLs detected at p = 10−5), and the AUC is significantly different from 0.5 at each level of significance.

When high trait heritability was used as the criterion to identify transcripts for which genetic linkage is expected to be more reliable, a significant proportion of eQTLs could not be detected. Given the actual number of eQTLs mapped with genome-wide significance in this study, we calculated the percentage of cis- and trans-eQTLs that will be discarded when various h2trait cut-offs are used (Figure 2). For example, if h2trait = 20% is accepted as a prerequisite to map an eQTL and hence eQTLs called from transcripts showing h2trait < 20% are not considered, 65% to 80% of the trans-eQTLs and 10% to 40% of the cis-eQTLs will be excluded from the eQTL dataset (Figure 2).

Figure 2
Proportion of eQTLs That Are Excluded when Transcripts are Filtered Based on h2trait

Power to Detect Cis and Trans Effects and False Discovery Rate

Figure 3A shows the power for the minimum detectable effect at different h2trait values when allelic effects are in the range 0–0.30 (i.e., absolute FC between one and 1.52). For effects greater than 0.25, the power tends to 100% for all considered values of h2trait. Small effects are detected with low power, and when the h2trait is 0.8–0.9, we achieve ~75% power for an effect of 0.10, which is equivalent to an absolute FC of 1.15. For lower heritabilities of the trait (h2trait = 0.2–0.3), the minimum detectable eQTL effect is higher, ~0.12 (i.e., an absolute FC of 1.18). The power to detect small effects increases with the number of biological replicates within each strain, with a significant improvement observed in the range of two to six replicates (Figure S4), and with the number of RI lines (Figure S5). Similar analyses showed that the power increases for eQTLs mapped at higher significance levels (unpublished data), indicating that stronger effects are associated with lower p-values.

Figure 3
Power to Detect a Major eQTL in the RI Strains

Given the effects for cis- and trans-eQTLs detected with genome-wide significance in this study (Table 1), we derived the expected power for the cis and trans allelic effects in the LV, fat, kidney, and adrenal tissue. Figure 3B shows that the maximum expected power to detect average effects of trans-eQTLs is low in all tissues, ranging from 12% to 60% (at high h2trait). In contrast, the cis-regulated genes are expected to be detectable with high power across all tissues. As indicated by tissue-specific allelic effects of the trans-eQTL, we expect different power for trans-regulated genes across tissues (Figure 3B).

The lower power to detect trans-eQTLs at p = 0.05 in kidney and adrenal is reflected in the tissue-specific false discovery rate (FDR) (Figure 4A). At p = 0.05, we observe an FDR of ~35% in kidney and adrenal, whereas the FDR is only 26% in LV and fat. This difference in FDR is noticeable for a p-value cut-off of >10−3, and below this threshold all linkage datasets show similar FDR patterns (Figure 4A, insert). Given that trans-acting eQTLs are normally detected at higher p-value thresholds, they show higher FDR levels than cis-regulated genes (Figure 4B). Across all tissues, at p = 0.05 the median FDR ranges from 4% to 8% for the cis-eQTLs and from 19% to 27% for the trans-eQTLs. For trans-acting eQTLs, kidney and adrenal show higher FDR levels (median 24%–27%) than LV and fat tissues (median FDR 19%–20%).

Figure 4
FDR in LV, Fat, Kidney, and Adrenal Tissues

Discussion

We investigated the overall sensitivity of the genetical genomics approach to discriminate between cis and trans regulation within and between tissues. Our analysis was carried out in the BXH/HXB panel of rat RI strains and in four tissues: LV, fat, kidney, and adrenal, from which expression profiles were generated. RI strains are a suitable genetic system for global analysis of heritable patterns of gene expression, allowing direct estimation of genetic and environmental components of phenotypic variance [22]. We examined how cis and trans genetic factors contributed to the global heritability of gene expression observed across tissues. Quantifying the extent of such contributions is of great importance to understand how genetic influences of gene expression are structured within the population and may occur unevenly in the context of specific tissues [26].

We provided evidence for a significant heritable component of quantitative variation of gene expression in all tissues. On the whole, at least 20% of the transcripts showed h2trait > 20%, and the overall proportion of heritable genes was similar across all tissues (Figure S2). The value of h2trait is higher for those transcripts that were mapped to cis-acting eQTLs (31%–51%) than trans-eQTLs (12%–21%), thus suggesting that larger differences in transcript abundance are associated with cis-acting genetic variation in gene expression (Table 1). Although h2trait is positively correlated with the average levels of expression, the proportions of heritable transcripts do not vary by the levels of expression observed in different tissues (unpublished data). We also observed that amount of variation in gene expression levels is consistent across tissues, indicating that the estimates of heritability are not significantly influenced by intra-specific variability between tissues (see Materials and Methods).

It is commonly accepted that the power and precision of genetic mapping will be significantly affected by the magnitude of trait heritability [27]. In practice, the larger the environmental variance (i.e., lower h2trait), the less likely an eQTL will be detected. However, detection of a significant eQTL does not appear to be entirely determined by the sole estimate of h2trait. We showed that in large-scale analysis of gene expression phenotypes, h2trait by itself is not a consistent predictor of the eQTLs, and its efficiency depends considerably on the p-value thresholds at which eQTLs are mapped (Figure S3; Table S1). In addition, we have shown that at each level of significance of the eQTL, h2trait is an unreliable parameter in predicting putative trans-eQTLs. When h2trait is used as a filter to improve detection of linkages [16,17,24], a significant proportion of eQTLs will be discarded from the study. For example, we have shown that conservative filtering approaches (h2trait > 20%) result in a significant decrease (65%–80%) in the trans-acting eQTLs detected with genome-wide significance (Figure 2). This could have important consequences for identification of clusters of trans-acting eQTLs, or trans-eQTL “hotspots”, which may represent common regulation by a single gene. It should also be noted that the relative proportion of trans-acting eQTLs tends to drop as the statistical significance for eQTL detection is increased (Table 1). This suggests that using conservative filtering approaches may result in many false negatives and in fewer trans-eQTL “hotspots” being identified, biasing detection towards cis-acting eQTLs.

The relationship between h2trait and different detection of cis- and trans-eQTLs may be a result of their specific mono-, oligo-, or polygenic influences on gene expression. Because sequence variations within single cis-acting genes may have a substantial impact on transcription, the measured heritability of gene expression can be very high, indicating existence of major cis-regulated eQTLs that explain most of the phenotypic variance [13]. This argument may account for the better efficiency of h2trait in predicting highly significant cis-eQTLs, since most of them are expected to be inherited essentially as monogenic traits. We found that whilst cis-eQTLs have substantial h2QTL (26%–31%), the median h2QTL observed for trans-eQTLs mapped at p = 0.05 is only 20%–23%. However, at higher levels of significance we observed more robust h2QTL values for both cis and trans loci (Table 1). This can be indicative of an over-estimate of the eQTL effect size due to the relatively small sample size (Beavis effect [28]) or of a combined effect of a number of physically linked QTLs of small effect [27]. Importantly, we detected only a small proportion of eQTLs (mostly cis-acting) that exhibit big allelic effects and account for more than 40% of the phenotypic variance. These data suggest that global variation in gene expression is also likely to be under the influence of multiple loci with small effect alongside a major cis-eQTL. This explanation is consistent with previous data in yeast, where only 3% of highly heritable transcripts are explained by single-locus (i.e., monogenic) inheritance and 50% are consistent with more than five controlling loci of equal effect [29,30].

We and others [5] detected a substantial relative proportion (54%–64%) of trans-acting eQTLs at p = 0.05, and this percentage decreases at higher levels of significance [11]. At each cut-off for linkage, the median effect observed for trans-eQTLs (0.06–0.11, FC 1.09–1.16) is well below that observed for the cis-eQTLs (0.14–0.37, FC 1.21–1.67). This suggests that detection of cis-eQTLs will be facilitated because of their larger effects and that, on a large scale, this study design is more sensitive for detection of cis than trans effects. We showed that when h2trait is greater than 10%, the expected power to detect major cis-eQTLs is greater than 70% in all tissues. In contrast, detection of trans-eQTLs is limited by low statistical power (12%–60%), as a result of their generally smaller genetic effects. For the eQTLs detected at p = 0.05, we observed tissue-specific differences in the allelic effects of both cis- and trans-eQTLs. In particular, kidney and adrenal tissues showed enrichment of trans-eQTLs with smaller effects (Figure S6). Although these differences are negligible for detection of cis-eQTLs, they appear to be significant for detection of trans-eQTLs. We found that, when the major eQTL is trans-acting, minor differences in allelic effects are expected to have a significant influence on the statistical power to detect trans-eQTLs (Figure 3B). As a result, at genome-wide significance, where the majority of eQTLs are regulated in trans, kidney and adrenal showed a higher proportion of false positives among the detected eQTLs (FDR 34%–36%) than that observed in LV and fat tissues (FDR ~26%). Our data indicate that trans-eQTLs account for most of the high FDR expected at p = 0.05 (Figure 4B), and this goes together with the difference in the statistical power for cis- or trans-eQTLs across tissues. This observation has a number of possible explanations. First, technical variability in microarray experiments (e.g., due to quality of tissue samples or inherent homogeneity of hybridization [31]) may account for the different sensitivity to trans-eQTLs across experiments. However, if this is the case, we should not observe a similar extent of variability and h2trait consistent in all tissues. Therefore, we can exclude technical variation as the primary or sole cause of different sensitivity to trans-eQTL effects. Second, actual differences in tissue composition may influence the ability and power to detect trans-eQTLs by linkage and the FDR in this study design. It is plausible that the increase of biological variability in more complex and heterogeneous tissues—such as adrenal and kidney—or susceptibility to transcription variation in response to environmental stimuli could explain the observed distribution of trans-eQTL effects.

Although the patterns of heritable gene expression were similar across tissues, the fat eQTL dataset showed a set of 20 trans-regulated genes with high allelic effect (>0.30) but low heritability of the eQTL (h2QTL ~ 0.2; Figure 1). Inspection of the biological function of these genes revealed that they are all highly expressed in skeletal muscle belonging to the sarcomeric skeletal muscle contractile apparatus. Because the peritoneal fat pad sits in close proximity to the retroperitoneal muscle, and there was marked, but highly correlated, intra-strain variability in raw expression values of this set of genes (i.e., low h2QTL), we consider it likely that this cluster of apparent trans-eQTL effects is due to contamination of the fat pad samples with small quantities of skeletal muscle. Apart from this cluster of skeletal muscle genes, there are very few if any trans-eQTL genes from fat or other tissues showing a similar pattern of low h2QTL and high eQTL allelic effect. This finding suggests that this possibly confounding effect is limited to this cluster of genes and does not have a significant bearing on the other trans linkages identified in our studies. However, it shows the sensitivity of this experimental design to tissue sampling variability, and the value of this type of analysis for demonstrating the integrity of eQTL datasets.

In summary, this is to our knowledge the first report to address the relative sensitivity to detect cis- and trans-eQTL effects based on the observed patterns of heritable gene expression across multiple tissues and that takes into account their thresholds of detection and FDR. Trans-regulated genes showed small genetic effects that affect the power to detect these eQTLs in different tissues. Although variability in gene expression across tissues is well known [31], we believe that the higher FDR levels for trans-eQTL genes in adrenal and kidney may be correlated to high cellular heterogeneity of those tissues, compared to LV or fat. Importantly, tissue-specific features of the trans-regulated genes are not explained by either observed patterns of heritable gene expression or variability of expression levels. When major-effect eQTLs are mapped in trans, their detection may be precluded by overly stringent statistical cut-offs of significance or by adopting conservative filtering approaches based on trait heritability. This is likely to occur to different extents in different tissues, and we showed that it is a function of the allelic effects of trans-eQTLs. Thus, integration of data from multiple sources requires careful consideration and may, in some cases, not be appropriate. For cis-eQTLs, detection is enhanced by their bigger effects, and the identification of shared cis-acting regulators of gene expression between tissues is facilitated. Because of their more complex and polygenic nature, the profiles of trans-acting eQTLs are likely due to tissue-specific regulation, thus limiting the detectable shared trans-eQTLs across experiments [3,11,16]. By examining genome-wide expression and linkage data from four tissues, we provide here a detailed picture of cis- and trans-eQTL features that may help in understanding the genetic regulation of transcription. This study highlights that large-scale identification of trans-acting loci can be strongly influenced by tissue-specific factors, which are likely to be key determinants in the feasibility of discovering regulatory gene networks at the level of the organism.

Materials and Methods

RI strains and tissues.

The set of 30 RI strains used in this study was produced by inbreeding between members of the F2 generation resulting from the cross of the two highly inbred strains BN.Lx/Cub and SHR/Ola [18], designated here as BN and SHR. Rats were housed in an air-conditioned animal facility and allowed free access to standard laboratory chow and water. All experiments were performed in agreement with the Animal Protection Law of the Czech Republic (311/1997) and were approved by the Ethics Committee of the Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Animals were killed at 6 wk of age. Tissues from four unfasted males of each RI strain were harvested between 9 and 10 a.m., immediately removed, frozen in liquid nitrogen, and stored at −80 °C.

Microarray analysis.

The original experimental design is discussed in Hubner et al. [11]. In addition to the fat and kidney data described, we also analysed adrenal and LV data (T. J. Aitman, M. Pravenec, N. Hubner, and S. A. Cook, unpublished data) from the same panel of RI strains and experimental design. Gene expression summary values for Affymetrix GeneChip data (Affymetrix, Santa Clara, California, United States) were computed using the Robust Multichip Average algorithm [32]. In this study, we used a total of 480 microarrays: four animals × 30 RI strains × four tissues. Each individual tissue experiment consisted of 120 array datasets, which were processed and normalised separately. For fat, kidney, and adrenal tissues, cRNA was labelled and run on RAE 230A Affymetrix GeneChip arrays (number of transcripts 15,923). For LV tissue, cRNA was labelled and run on RAE 230_2 Affymetrix GeneChip arrays (number of transcripts 31,099).

Expression levels were generated and analysed independently for each tissue. The mean (SE) expression levels measured across 30 RI strains were 5.26 (0.01) for LV, 7.23 (0.02) for fat, 6.55 (0.01) for kidney, and 5.94 (0.01) for adrenal. The experimental variation within each tissue was evaluated through the coefficient of variation of gene expression among all transcripts represented in the microarrays. For all transcripts the average coefficient of variation (SE) was 3% (0.0001) for LV and 2% (0.0001) for fat, kidney, and adrenal tissues. The observed range of coefficients of variation was 0.3%–38% for LV, 0.4%–31% for fat, 0.3%–26% for kidney, and 0.8%–32% for adrenal. These estimates indicate that no significant differences were observed in the intra-specific variability of gene expression levels between tissues.

For this analysis we selected probesets that were mapped to the genome by Ensembl [33]. In order to avoid misclassification of cis- and trans-eQTLs, we also removed probesets that mapped to more than one place in the genome, resulting in 13,669 individual transcripts for fat, kidney, and adrenal and 27,168 individual transcripts for LV.

Heritability of gene expression.

The narrow-sense h2trait in a set of RI lines was estimated using the method of Hegmann and Possidente [34], h2trait = 0.5VA/(0.5VA + VE), where VA represents the additive genetic component (variances of strain means) and VE the average environmental component (variances within strains) [22]. Adjustments are usually required to correct for the fact that variance of strain means contains a proportion of the environmental component of variance. However, under conditions of reasonably large sample sizes from strains and relatively low variance/covariance within strains, this factor can be excluded from calculation. Because the correlation between the heritability estimates obtained using the complete and simplified formulas is very high (r2 > 0.99), all estimates of h2trait discussed here were calculated using the simplified formula. Chi-square test for homogeneity and Spearman's correlations were calculated using SPSS 12.0 (SPSS, Chicago, Illinois, United States).

Mapping of eQTLs.

We carried out genome-wide linkage analysis for each expression trait dataset generated in the RI strains in fat, kidney [11], adrenal, and LV tissues, and 1,011 genetic markers using the QTL Reaper program (http://sourceforge.net/projects/qtlreaper). For each transcript we calculated the likelihood ratio statistics for linkage and its empirical genome-wide significance [35] by permutations as previously described [11]. To account for multiple testing of thousands of expression traits, we calculated the FDR [36] and evaluated the expected number of falsely discovered eQTLs at each level of significance. The FDR of the cis- and trans-acting eQTLs was represented by vase box-plots [37], using the R package UsingR (http://www.math.csi.cuny.edu/UsingR) [38].

Characterisation of eQTLs.

In this study, we empirically defined a cis-acting eQTL as having the peak of linkage within 10 Mbp of the physical location of the probeset and a trans-acting eQTL as having the peak of linkage on a different chromosome from where the probeset is located. Additive genetic effects (i.e., QTL allelic effects) and heritability of the eQTLs (h2QTL) were calculated for each cis- and trans-eQTL. eQTL effects are an estimate of the absolute change in the transcript abundance that would be produced by substituting a single allele of one type with that of another type in the population. For each eQTL, its allelic effect is calculated as |MEANSHR − MEANBN |/2, where MEANSHR and MEANBN are the means of gene expression levels of all rats that respectively inherited SHR and BN alleles at the marker peak of linkage. The value h2QTL is the proportion of phenotypic variance that is attributable to the eQTL [39], and it is calculated from the squared allelic effect and the error variance segregating in the RI strains [40].

Power calculation.

We calculated the expected statistical power to detect a major eQTL effect in the RI strains using the R package R/qtl Design (http://www.biostat.ucsf.edu/sen/software.html) [41]. In order to model various trait heritabilities, we considered different genetic and environmental variances within the experimental range observed in the RI strains across four tissues and used those estimates to calculate the power to detect a given additive effect of the eQTL [40]. The threshold used for detecting an eQTL was log of the odds score = 3.3 (i.e., genome-wide p = 0.05 [42]); 30 RI strains were considered. Similarly, we carried out additional power calculations and modelled the number of RI lines (30–200) and several thresholds of significance corresponding to those reported in this study.

ROC curves.

For each transcript, the estimated h2trait was tested as a predictor of the presence of an eQTL (as detected by linkage) via ROC curve. ROC curves are plots of the true positive rate (sensitivity) of a diagnostic test against the test's false positive rate (1 − specificity) for various decision thresholds (i.e., various p-value cut-offs). The AUC measures the probability of correct classification, i.e., the ability of the trait heritability to correctly classify those eQTLs that will be (or will not be) detected in the linkage study. For a perfect prediction, the AUC will tend to be close to one and the ROC curve would follow the left-hand border and then the top border of the ROC space [25]. Non-parametric estimates of AUC and its SE were carried out using SPSS 12.0.

Supporting Information

Figure S1

Comparison of Heritability of Gene Expression across Different Tissues:

Heritability of gene expression trait in the BXH/HXB panel of RI strains was calculated for each individual transcript considered in this study. The dotted line indicates the median heritability of gene expression. The histograms show similar distributions with a considerable heritability of gene expression in all tissues. The chi-square test did not show significant differences (p > 0.05 in all comparisons) between the distributions of heritability in different tissues.

(91 KB PPT)

Figure S2

Cumulative Frequency Curves of the Distribution of Transcripts Observed with a Given Heritability of Gene Expression in LV, Fat, Kidney, and Adrenal Tissues:

The relative proportions of heritable transcripts are similar in all tissues.

(46 KB PDF)

Figure S3

Comparison of ROC Curves for Prediction of Existence of a Detectable eQTL by Heritability of Gene Expression for LV, Fat, Kidney, and Adrenal Tissues:

Significantly detected eQTLs were defined at several levels of significance (p-value cut-offs 0.05, 10−2, 10−3, 10−4, and 10−5), and the relative ROC curves are compared. The vertical axis shows the fraction of major eQTLs that are correctly predicted (sensitivity) by the h2trait, whereas the horizontal axis indicates the fraction of major eQTLs that are incorrectly predicted (1 − specificity) by the estimate of the h2trait. The closer the ROC curve is to the upper left-hand corner of the graph, the more accurate is the prediction of the eQTL (i.e., higher true positive rate and lower false positive rate). The areas under the ROC curves are reported in Table S1.

(3.5 MB PPT)

Figure S4

Statistical Power to Detect an eQTL with Allelic Effects 0.06, 0.1, 0.15, and 0.2 (FC 1.09, 1.15, 1.23, and 1.32)

Various estimates of heritability of gene expression were modelled, and 30 RI strains were considered (see Materials and Methods).

(67 KB PPT)

Figure S5

Statistical Power to Detect an eQTL with Allelic Effect 0.1 (i.e., FC 1.15) as a Function of the Number of RI Strains:

Various estimates of heritability of gene expression were modelled, and four biological replicates were considered.

(39 KB PPT)

Figure S6

Cumulative Frequency Curves of the Distribution of Trans-eQTLs Detected with Genome-Wide Significance (p = 0.05) with a Given Allelic Effect in LV, Fat, Kidney, and Adrenal Tissues:

We observe an enrichment of trans-eQTLs with small allelic effects in the range 0–0.8 for kidney and adrenal tissues compared with LV and fat. Insert: cumulative frequency curves of the distribution of trans-eQTLs for allelic effects are in the range 0–0.16.

(57 KB PPT)

Table S1

AUCs for Prediction of Existence of a Detectable eQTL by Heritability of Gene Expression for LV, Fat, Kidney, and Adrenal Tissues:

(46 KB DOC)

Acknowledgments

We thank Mario Falchi for constructive criticism of the manuscript and the Clinical Sciences Centre/Imperial College Microarray Centre for technical assistance with the microarray data. We thank the three anonymous reviewers for their critical comments on the manuscript.

Abbreviations

AUC
area under the receiver operating characteristic curve
BN
Brown Norway
eQTL
expression quantitative trait locus
FC
fold change
FDR
false discovery rate
h2QTL
heritability of the QTL
h2trait
trait heritability
LV
left ventricle
QTL
quantitative trait locus
RI
recombinant inbred
ROC
receiver operating characteristic
SE
standard error
SHR
spontaneously hypertensive rat

Footnotes

Competing interests. The authors have declared that no competing interests exist.

A previous version of this article appeared as an Early Online Release on August 28, 2006 (DOI: 10.1371/journal.pgen.0020172.eor).

Author contributions. EP conceived, designed and wrote the paper, with contributions from JM, NJD, SAC, NH, and TJA. MKK, HL, JF, and HM performed the experiments. EP analyzed the data. NJD, SAC, JM, VK, NH, and MP contributed reagents/materials/analysis tools.

Funding. We acknowledge funding to TJA from the Medical Research Council Clinical Sciences Centre, from the Wellcome Trust Cardiovascular Functional Genomics and BAIR awards; to NH from the German Ministry for Science and Education (BMBF/NGFN); to MP from the Grant Agency of the Czech Republic and from the Ministry of Education of the Czech Republic; to MP and TJA from the Wellcome Trust Collaborative Research Initiative Grant; to NH, MP, and TA from the European Union–funded EURATools Integrated Project; to SAC and HL from the UK Department of Health; and to VK from the Ministry of Education of the Czech Republic (MSM0021620807). MP is an International Research Scholar of the Howard Hughes Medical Institute.

References

  • Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, et al. Mapping determinants of human gene expression by regional and genome-wide association. Nature. 2005;437:1365–1369. [PMC free article] [PubMed]
  • Brem RB, Yvert G, Clinton R, Kruglyak L. Genetic dissection of transcriptional regulation in budding yeast. Science. 2002;296:752–755. [PubMed]
  • Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature. 2003;422:297–302. [PubMed]
  • Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. Genetic analysis of genome-wide variation in human gene expression. Nature. 2004;430:743–747. [PMC free article] [PubMed]
  • Yvert G, Brem RB, Whittle J, Akey JM, Foss E, et al. Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors. Nat Genet. 2003;35:57–64. [PubMed]
  • Damerval C, Maurice A, Josse JM, de Vienne D. Quantitative trait loci underlying gene product variation: A novel perspective for analyzing regulation of genome expression. Genetics. 1994;137:289–301. [PMC free article] [PubMed]
  • Jansen RC, Nap JP. Genetical genomics: The added value from segregation. Trends Genet. 2001;17:388–391. [PubMed]
  • Li J, Burmeister M. Genetical genomics: Combining genetics with gene expression analysis. Hum Mol Genet 14 (Spec No. 2) 2005. pp. R163–R169. [PubMed]
  • Li H, Chen H, Bao L, Manly KF, Chesler EJ, et al. Integrative genetic analysis of transcription modules: Towards filling the gap between genetic loci and inherited traits. Hum Mol Genet. 2006;15:481–492. [PubMed]
  • Li H, Lu L, Manly KF, Chesler EJ, Bao L, et al. Inferring gene transcriptional modulatory relations: A genetical genomics approach. Hum Mol Genet. 2005;14:1119–1125. [PubMed]
  • Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet. 2005;37:243–253. [PubMed]
  • Doss S, Schadt EE, Drake TA, Lusis AJ. Cis-acting expression quantitative trait loci in mice. Genome Res. 2005;15:681–691. [PMC free article] [PubMed]
  • Gibson G, Weir B. The quantitative genetics of transcription. Trends Genet. 2005;21:616–623. [PubMed]
  • Manly KF, Nettleton D, Hwang JT. Genomics, prior probability, and statistical tests of multiple hypotheses. Genome Res. 2004;14:997–1001. [PubMed]
  • Stamatoyannopoulos JA. The genomics of gene expression. Genomics. 2004;84:449–457. [PubMed]
  • Chesler EJ, Lu L, Shou S, Qu Y, Gu J, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet. 2005;37:233–242. [PubMed]
  • Bystrykh L, Weersing E, Dontje B, Sutton S, Pletcher MT, et al. Uncovering regulatory pathways that affect hematopoietic stem cell function using ‘genetical genomics'. Nat Genet. 2005;37:225–232. [PubMed]
  • Pravenec M, Klir P, Kren V, Zicha J, Kunes J. An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains. J Hypertens. 1989;7:217–221. [PubMed]
  • Pravenec M, Zidek V, Landa V, Simakova M, Mlejnek P, et al. Genetic analysis of “metabolic syndrome” in the spontaneously hypertensive rat. Physiol Res. 2004;53((Suppl 1)):S15–S22. [PubMed]
  • Aitman TJ, Gotoda T, Evans AL, Imrie H, Heath KE, et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet. 1997;16:197–201. [PubMed]
  • Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 1999;21:76–83. [PubMed]
  • Belknap JK. Effect of within-strain sample size on QTL detection and mapping using recombinant inbred mouse strains. Behav Genet. 1998;28:29–38. [PubMed]
  • Crusio WE. A note on the effect of within-strain sample sizes on QTL mapping in recombinant inbred strain studies. Genes Brain Behav. 2004;3:249–251. [PubMed]
  • Chesler EJ, Bystrykh L, de Haan G, Cooke MP, Su A, et al. Reply to “Normalization procedures and detection of linkage signal in genetical-genomics experiments” Nat Genet. 2006;38:856–858.
  • Pepe MS. An interpretation for the ROC curve and inference using GLM procedures. Biometrics. 2000;56:352–359. [PubMed]
  • Sladek R, Hudson TJ. Elucidating cis- and trans-regulatory variation using genetical genomics. Trends Genet. 2006;22:245–250. [PubMed]
  • Flint J, Valdar W, Shifman S, Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet. 2005;6:271–286. [PubMed]
  • Xu S. Theoretical basis of the Beavis effect. Genetics. 2003;165:2259–2268. [PMC free article] [PubMed]
  • Brem RB, Kruglyak L. The landscape of genetic complexity across 5,700 gene expression traits in yeast. Proc Natl Acad Sci U S A. 2005;102:1572–1577. [PMC free article] [PubMed]
  • Brem RB, Storey JD, Whittle J, Kruglyak L. Genetic interactions between polymorphisms that affect gene expression in yeast. Nature. 2005;436:701–703. [PMC free article] [PubMed]
  • Novak JP, Sladek R, Hudson TJ. Characterization of variability in large-scale gene expression data: Implications for study design. Genomics. 2002;79:104–113. [PubMed]
  • Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264. [PubMed]
  • Birney E, Andrews D, Caccamo M, Chen Y, Clarke L, et al. Ensembl 2006. Nucleic Acids Res. 2006;34:D556–D561. [PMC free article] [PubMed]
  • Hegmann JP, Possidente B. Estimating genetic correlations from inbred strains. Behav Genet. 1981;11:103–114. [PubMed]
  • Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963–971. [PMC free article] [PubMed]
  • Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B. 2002;64:479–498.
  • Benjamini Y. Opening the box of a boxplot. Am Stat. 1988;42:257–262.
  • Verzani J. Using R for introductory statistics. Boca Raton: Chapman & Hall/CRC Press; 2005. 414 p.
  • Lynch M, Walsh B. Genetics and analysis of quantitative traits. Sunderland (Massachusetts): Sinauer Associates; 1998. 980 p.
  • Sen S, Satagopan JM, Churchill GA. Quantitative trait locus study design from an information perspective. Genetics. 2005;170:447–464. [PMC free article] [PubMed]
  • Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics. 2003;19:889–890. [PubMed]
  • Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241–247. [PubMed]

Articles from PLoS Genetics are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Links